Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-345613
Filing Date
2012-08-09
Accepted
2012-08-09 08:03:02
Documents
11
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d344871d10q.htm 10-Q 601665
2 EX-31.1 d344871dex311.htm EX-31.1 6256
3 EX-31.2 d344871dex312.htm EX-31.2 6227
4 EX-32.1 d344871dex321.htm EX-32.1 3165
5 EX-32.2 d344871dex322.htm EX-32.2 3149
  Complete submission text file 0001193125-12-345613.txt   2919622

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT orex-20120630.xml EX-101.INS 390967
7 XBRL TAXONOMY EXTENSION SCHEMA orex-20120630.xsd EX-101.SCH 22460
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE orex-20120630_cal.xml EX-101.CAL 41893
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE orex-20120630_def.xml EX-101.DEF 61450
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE orex-20120630_lab.xml EX-101.LAB 182924
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE orex-20120630_pre.xml EX-101.PRE 132897
Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Filer) CIK: 0001382911 (see all company filings)

EIN.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33415 | Film No.: 121018563
SIC: 2834 Pharmaceutical Preparations